About Mikko
PhD, Professor of Cell and Tissue Biology, has identified novel AD-related genes and characterized their molecular mechanisms in in vitro and in vivo models and human brain. His group has been part of the recent GWA, meta-analysis and cerebrospinal fluid (CSF)-based endophenotype studies identifying several novel AD risk gene variants. Prof. Hiltunen is a site PI in EADB project focusing on deciphering the missing heritability of AD using to date the largest GWA-based data analysis of tens of thousands AD patients and control subjects. Some of the identified targets are potential new early biomarkers for early diagnosis and disease progression of AD. Prof. Hiltunen belongs to significant national and international discovery networks, such as EADB and International Genomics of Alzheimer’s Project. Furthermore, Prof. Hiltunen has established collaboration with leading AD research groups at the German Center for Neurodegenerative Diseases (DZNE).
Bibliographic data
Over 190 Publications
Supervision
- 14 PhD students
- 7 postdocs
Currently:
- 1 Academy Postdoctoral Fellow
- 2 postdocs
- 5 PhD students
- 1 technician
Funding
- Academy of Finland
- JPND-funding
- H2020 PANA
- MSCA COFUND
- Sigrid Juselius Foundation
- academic collaboration funding with pharmaceutical industry
Leadership
- Vice-Director of UEF Program in Neurosciences 2016-2020
- Director of Doctoral Program for Molecular Medicine
- UEF (2016-2020)
- Director of GenomMed Doctoral Program
- MSCA COFUND
- UEF (2017-2022)